John Wilkerson , 2025-04-16 19:57:00
WASHINGTON — The Trump administration has an expansive view for how it can lower drug prices for Americans.
It has been here before. The question is whether this time will be different.
During his first term, President Trump tried to tie U.S. drug prices to those in other rich nations, but the Biden administration rescinded that “most favored nation” policy after a federal court stopped it from taking effect. A plan to overhaul how doctors buy and bill for drugs never got off of the ground. The same fate befell Trump’s plan to make insurers pass drug rebates directly to patients at the pharmacy counter. Similarly, the Supreme Court shot down a policy of significantly reducing Medicare payments to hospitals for administering drugs bought through a government discount program called 340B.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.